Critical Path Paved With Fewer Patients
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA Deputy Commissioner Gottlieb says that the agency's innovation initiative will produce smaller trial requirements stemming from a better understanding of drug mechanics.
You may also be interested in...
FDA To Issue Five Guidances On Adaptive Clinical Trial Design
The agency will issue a total of five guidance documents regarding adaptive clinical trials, the first of which will examine using multiple endpoints in the same trial.
Future BIO Global Efforts Include International Relations, Greenwood Says
HAMBURG, Germany - Due to the increasingly global nature of biotechnology, the Biotechnology Industry Organization's board of directors will meet next month to discuss a proposal to expand its global reach and potentially create a department of international relations, BIO President Jim Greenwood said Nov. 13